Anthocyanins inhibit high-glucose-induced cholesterol accumulation and inflammation by activating LXRα pathway in

Chunyang Du1, Yonghong Shi1, Yunzhuo Ren1

  • 1Department of Pathology, Hebei Medical University, Shijiazhuang, People's Republic of China ; Hebei Key Laboratory of Kidney Diseases, Shijiazhuang, People's Republic of China.

Insights

Anthocyanins improve cholesterol efflux and reduce inflammation in diabetic nephropathy cells by activating the PPARα-LXRα-ABCA1 pathway. This suggests a potential therapeutic role for anthocyanins in managing diabetic kidney disease.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Diabetic nephropathy (DN) progression is linked to disrupted cholesterol metabolism and inflammation.
  • Anthocyanins, found in food, possess antioxidant, anti-inflammatory, and lipid-lowering properties.
  • The specific mechanisms of anthocyanins in DN, particularly regarding cholesterol efflux and inflammation, require further elucidation.

Purpose of the Study:

  • To investigate the effects of anthocyanins (cyanidin-3-O-β-glucoside chloride [C3G] and cyanidin chloride [Cy]) on cholesterol metabolism and inflammation in high-glucose (HG)-stimulated HK-2 cells.
  • To elucidate the molecular mechanisms underlying anthocyanin action, focusing on the interplay between cholesterol efflux and inflammatory pathways.

Main Methods:

  • Utilized high-glucose (HG)-stimulated HK-2 cells to model aspects of diabetic nephropathy.
  • Assessed the impact of anthocyanins on cholesterol efflux, ABCA1 expression, and the expression of key signaling molecules including PPARα, LXRα, and NFκB.
  • Employed a PPARα-specific inhibitor (GW6471) and LXRα shRNA to investigate the roles of these receptors in mediating anthocyanin effects.
  • Examined the expression of pro-inflammatory cytokines (ICAM1, MCP1, TGFβ1) and NFκB activation.

Main Results:

  • Anthocyanins significantly enhanced cholesterol efflux and ABCA1 expression in HK-2 cells.
  • Anthocyanins increased PPARα and LXRα expression and suppressed HG-induced pro-inflammatory cytokine expression (ICAM1, MCP1, TGFβ1) and NFκB activation.
  • Inhibition of PPARα or LXRα attenuated anthocyanin-induced cholesterol efflux, indicating a PPARα-LXRα-ABCA1-dependent mechanism.
  • LXRα knockout abolished the anti-inflammatory effects of anthocyanins, suggesting LXRα's crucial role in mediating these effects, potentially by modulating NFκB nuclear translocation.

Conclusions:

  • Anthocyanins promote cholesterol efflux via the PPARα-LXRα-ABCA1 pathway in kidney cells.
  • Anthocyanins exert anti-inflammatory effects in DN models, primarily through the LXRα pathway's influence on NFκB signaling.
  • These findings highlight anthocyanins as potential agents for managing diabetic nephropathy by concurrently addressing cholesterol dysregulation and inflammation.